SS Innovations International, Inc. (NASDAQ:SSII – Get Free Report) shares fell 6.8% during trading on Friday . The stock traded as low as $4.54 and last traded at $4.6210. 74,351 shares were traded during trading, a decline of 28% from the average session volume of 103,491 shares. The stock had previously closed at $4.96.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SS Innovations International in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
Read Our Latest Analysis on SSII
SS Innovations International Trading Down 10.1%
SS Innovations International (NASDAQ:SSII – Get Free Report) last posted its earnings results on Tuesday, March 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $14.53 million during the quarter. SS Innovations International had a negative net margin of 28.54% and a negative return on equity of 30.23%.
Insider Activity
In other SS Innovations International news, Director Frederic H. Moll purchased 501,253 shares of the stock in a transaction dated Friday, March 6th. The shares were bought at an average cost of $3.99 per share, with a total value of $1,999,999.47. Following the completion of the transaction, the director owned 10,775,485 shares in the company, valued at $42,994,185.15. This trade represents a 4.88% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Srivastava Sudhir acquired 498,753 shares of the company’s stock in a transaction dated Friday, March 6th. The stock was acquired at an average price of $4.01 per share, for a total transaction of $1,999,999.53. Following the completion of the purchase, the chief executive officer directly owned 109,851,767 shares of the company’s stock, valued at $440,505,585.67. This trade represents a 0.46% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have acquired 1,300,006 shares of company stock valued at $5,196,999.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the business. Geode Capital Management LLC bought a new stake in SS Innovations International in the 2nd quarter valued at $122,000. Inspire Investing LLC bought a new position in SS Innovations International during the third quarter valued at about $240,000. Envestnet Asset Management Inc. acquired a new position in SS Innovations International in the 3rd quarter valued at approximately $71,000. PNC Financial Services Group Inc. acquired a new position in SS Innovations International in the 3rd quarter valued at approximately $56,000. Finally, Handelsbanken Fonder AB bought a new stake in shares of SS Innovations International in the 3rd quarter worth approximately $714,000.
About SS Innovations International
AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.
See Also
- Five stocks we like better than SS Innovations International
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
